Everest Organics Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Everest Organics Ltd is ₹ 267.45 as of 06 May 15:30 . The P/E Ratio of Everest Organics Ltd changed from 13.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 years The Market Cap of Everest Organics Ltd changed from ₹ 183.96 crore on March 2021 to ₹ 244.71 crore on March 2025 . This represents a CAGR of 5.87% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 years The Revenue of Everest Organics Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 . The EBITDA of Everest Organics Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 . The Net Profit of Everest Organics Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 . The Dividend Payout of Everest Organics Ltd changed from 8.75 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Everest Organics Ltd

Everest Organics Limited was incorporated at Hyderabad in February, 1993.
It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
The Company commenced its commercial operations in the year 1993.
It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Everest Organics Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Everest Organics Ltd or Vaishali Pharma Ltd?

Market cap of Everest Organics Ltd is 259 Cr while Market cap of Vaishali Pharma Ltd is 98 Cr

What are the key factors driving the stock performance of Everest Organics Ltd and Vaishali Pharma Ltd?

The stock performance of Everest Organics Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Everest Organics Ltd and Vaishali Pharma Ltd?

As of May 6, 2026, the Everest Organics Ltd stock price is INR ₹267.45. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.58.

How do dividend payouts of Everest Organics Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Everest Organics Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.